| Filed On | Filing |
|---|---|
| 18 Mar 2026 |
Form 4: Yeganeh Reuven, Director
Received 450,000 shares by conversion ($900K) · Sold 450,000 shares ($2.25M) · Disposed of 5,000,000 Common Stock Purchase Warrants (Open Market Sale) ($25.1M) · 2 more |
| 13 Mar 2026 |
Form 4: Yeganeh Reuven, Director
Received 300,000 shares by conversion ($600K) · Sold 300,000 shares ($1.5M) · Converted 600 Series Y Convertible Preferred Stock · 2 more |
| 23 Apr 2025 |
Form 4: Flynn James E, Director and 5 others
Granted 3,223,728 Warrants |
| 18 Apr 2025 |
Form 4: Flynn James E, Director and 1 other
Granted 17,600 Stock Option (Right to Buy) |
| 18 Apr 2025 |
Form 4: Wolfson Marina, Chief Financial Officer
Received 68,545 shares as a grant or award · Disposed of 95,000 Common Stock Options - right to Buy (Grant/Award Acquisition) |
| 18 Apr 2025 |
Form 4: Greig Russell, Director
Disposed of 35,200 Common Stock Options - right to Buy (Grant/Award Acquisition) |
| 18 Apr 2025 |
Form 4: Merril Gregory Louis, Director
Disposed of 17,600 Common Stock Options - right to Buy (Grant/Award Acquisition) |
| 18 Apr 2025 |
Form 4: Leff Jonathan S, Director
Disposed of 17,600 Common Stock Options - right to Buy (Grant/Award Acquisition) |
| 18 Apr 2025 |
Form 4: Goodman Jesse, Director
Disposed of 17,600 Common Stock Options - right to Buy (Grant/Award Acquisition) |
| 18 Apr 2025 |
Form 4: Bassan Merav, Chief Development Officer
Received 79,597 shares as a grant or award · Disposed of 95,000 Common Stock Options - right to Buy (Grant/Award Acquisition) |
| 18 Apr 2025 |
Form 4: Williams Eddie, Director
Disposed of 17,600 Common Stock Options - right to Buy (Grant/Award Acquisition) |
| 18 Apr 2025 |
Form 4: Moses Alan Charles, Director
Disposed of 17,600 Common Stock Options - right to Buy (Grant/Award Acquisition) |
| 18 Apr 2025 |
Form 4: Solomon Jonathan Eitan, Director
Received 126,748 shares as a grant or award · Disposed of 380,500 Common Stock Options - right to Buy (Grant/Award Acquisition) |
| 18 Apr 2025 |
Form 4: Blum Susan, Director
Disposed of 17,600 Common Stock Options - right to Buy (Grant/Award Acquisition) |
| 04 Mar 2025 | Form 4: Cystic Fibrosis Foundation, 10% owner |
| 03 Mar 2025 |
Form 4: Flynn James E, Director and 5 others
Received 706,498 shares by exercise or conversion ($657K) · Granted 2,517,228 Warrants |
| 18 Sep 2024 |
Form 4: Bassan Merav, Chief Development Officer
Received 31,749 shares as a grant or award |
| 18 Sep 2024 |
Form 4: Solomon Jonathan Eitan, Director
Received 50,556 shares as a grant or award |
| 18 Sep 2024 |
Form 4: Oron Assaf, Chief Business Officer
Received 25,804 shares as a grant or award |
| 17 Jul 2024 |
Form 4: Flynn James E, Director and 5 others
Received 11,766,000 shares by exercise or conversion |
Loading...
